(CLOB) VanEck Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: (N/A)
CLOB: CLOs, Bank Loans, Fixed Income, Securities
The VanEck ETF Trust (CLOB) is an actively managed exchange-traded fund that focuses on investing in collateralized loan obligations (CLOs) across various maturities. The funds investment strategy involves allocating at least 80% of its total assets to CLOs that are rated between AA+ and BB-, or those that are unrated but deemed to have comparable credit quality by the Adviser and/or PineBridge Investments LLC, the funds sub-adviser.
As a non-diversified fund, CLOBs investment approach is centered around the CLO market, which is a segment of the broader loan market that involves packaging loans into securities and selling them to investors. The funds exposure to this specific market segment allows it to capitalize on the income generated by the underlying loans, which are typically floating-rate and secured by corporate assets.
Given the current market conditions and the funds characteristics, we can analyze the technical data to identify potential trends. The recent price action indicates a relatively stable trend, with the last price at $50.42, slightly above the 20-day and 50-day simple moving averages (SMA). The 200-day SMA is at $49.46, suggesting a longer-term uptrend. The average true range (ATR) is $0.77, representing a 1.52% daily volatility.
Combining the technical analysis with the fundamental data, we can forecast the potential performance of CLOB. With an AUM of $99.95M USD, the fund has a relatively small asset base, which may impact its liquidity and trading dynamics. However, the current price is near the 52-week high, and the SMA indicators suggest a stable trend. Assuming the CLO market remains stable and the funds credit quality remains intact, we can expect CLOB to continue its current trend, potentially reaching $51.50 in the near term, representing a 2% increase from the current price.
To achieve this forecast, the fund would need to maintain its current investment strategy and continue to benefit from the income generated by the underlying CLOs. Any significant changes in market conditions, credit quality, or interest rates could impact the funds performance and alter this forecast.
Additional Sources for CLOB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CLOB ETF Overview
Market Cap in USD | 116m |
Category | Bank Loan |
IPO / Inception | 2024-09-24 |
CLOB ETF Ratings
Growth Rating | 20.4 |
Fundamental | - |
Dividend Rating | 50.3 |
Rel. Strength | 15.7 |
Analysts | - |
Fair Price Momentum | 49.52 USD |
Fair Price DCF | - |
CLOB Dividends
Dividend Yield 12m | 4.31% |
Yield on Cost 5y | 4.50% |
Annual Growth 5y | 26.07% |
Payout Consistency | 100.0% |
Payout Ratio | % |
CLOB Growth Ratios
Growth Correlation 3m | 69.2% |
Growth Correlation 12m | 78% |
Growth Correlation 5y | 78% |
CAGR 5y | 5.61% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | 0.45 |
Alpha | -0.68 |
Beta | 0.326 |
Volatility | 2.66% |
Current Volume | 29.8k |
Average Volume 20d | 11.4k |
As of June 18, 2025, the stock is trading at USD 50.65 with a total of 29,840 shares traded.
Over the past week, the price has changed by +0.31%, over one month by +0.82%, over three months by +1.44% and over the past year by +5.61%.
Neither. Based on ValueRay´s Analyses, VanEck Trust is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.40 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLOB is around 49.52 USD . This means that CLOB is currently overvalued and has a potential downside of -2.23%.
VanEck Trust has no consensus analysts rating.
According to our own proprietary Forecast Model, CLOB VanEck Trust will be worth about 54.1 in June 2026. The stock is currently trading at 50.65. This means that the stock has a potential upside of +6.75%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 54.1 | 6.8% |